Receptor T-Cell Chimeric Antigen Approach Used for the Prediction Model Treatment for Relapsed/Refractory Multiple Myeloma

被引：1
|
作者：
Yin, Zhao [1 ]
Zhang, Qing [1 ]
Ou, Ruiming [1 ]
Liu, Shuang [1 ]
机构：
[1] Guangdong Second Prov Gen Hosp, Dept Hematol, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 25期
关键词：
D O I：
10.1200/JCO.24.00544
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma
    Huang, He
    uW, Heng-wei
    Hu, Yong-xian
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2020, 21 (01): : 29 - 41
  • [2] Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma
    Chen, Wei
    Wang, Ying
    Qi, Kunming
    Shi, Ming
    Cao, Jiang
    Bhansali, Rahul
    Wang, Xue
    Liu, Yang
    Li, Hujun
    Zhang, Huanxin
    Yan, Zhiling
    Sang, Wei
    Cheng, Hai
    Zhu, Feng
    Sun, Haiying
    Li, Depeng
    Jing, Guangjun
    Zheng, Junnian
    Li, Zhenyu
    Xu, Kailin
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03): : 273.e1 - 273.e5
  • [3] Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment
    Hujun Li
    Lingling Yin
    Ying Wang
    Xiangmin Wang
    Ming Shi
    Jiang Cao
    Zhiling Yan
    Wei Sang
    Hai Cheng
    Feng Zhu
    Haiying Sun
    Depeng Li
    Guangjun Jing
    Junnian Zheng
    Zhenyu Li
    Kailin Xu
    Bone Marrow Transplantation, 2020, 55 : 2215 - 2218
  • [4] Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment
    Sidana, Surbhi
    Peres, Lauren C.
    Hashmi, Hamza
    Hosoya, Hitomi
    Ferreri, Christopher
    Khouri, Jack
    Dima, Danai
    Atrash, Shebli
    Voorhees, Peter
    Simmons, Gary
    Sborov, Douglas W.
    Kalariya, Nilesh
    Hovanky, Vanna
    Bharadwaj, Sushma
    Miklos, David
    Wagner, Charlotte
    Kocoglu, Mehmet H.
    Kaur, Gurbakhash
    Davis, James A.
    Midha, Shonali
    Janakiram, Murali
    Freeman, Ciara
    Alsina, Melissa
    Locke, Frederick
    Gonzalez, Rebecca
    Lin, Yi
    Mcguirk, Joseph
    Afrough, Aimaz
    Shune, Leyla
    Patel, Krina K.
    Hansen, Doris K.
    HAEMATOLOGICA, 2024, 109 (03) : 777 - 786
  • [5] Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment
    Li, Hujun
    Yin, Lingling
    Wang, Ying
    Wang, Xiangmin
    Shi, Ming
    Cao, Jiang
    Yan, Zhiling
    Sang, Wei
    Cheng, Hai
    Zhu, Feng
    Sun, Haiying
    Li, Depeng
    Jing, Guangjun
    Zheng, Junnian
    Li, Zhenyu
    Xu, Kailin
    BONE MARROW TRANSPLANTATION, 2020, 55 (11) : 2215 - 2218
  • [6] Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma
    Zhou, Dian
    Wang, Ying
    Cheng, Hai
    Zhu, Lili
    Chen, Wei
    Li, Hujun
    Zhang, Xiaotian
    Xia, Jieyun
    Qi, Yuekun
    Ma, Sha
    Zhu, Feng
    Yan, Zhiling
    Qi, Kunming
    Sang, Wei
    Sun, Haiying
    Li, Depeng
    Cao, Jiang
    Li, Zhenyu
    Xu, Kailin
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (02) : 179 - 185
  • [7] Vitamin D deficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma
    Nishimura, Noriko
    Flynn, Jessica
    Costa, Bruno
    Devlin, Sean
    Farzana, Tasmin
    Chung, David
    Landau, Heather
    Lahoud, Oscar
    Scordo, Michael
    Shah, Gunjan
    Hassoun, Hani
    Maclachlan, Kylee
    Hultcrantz, Malin
    Korde, Neha
    Lesokhin, Alexander
    Shah, Urvi
    Tan, Carlyn Rose
    Giralt, Sergio
    Usmani, Saad
    Mailankody, Sham
    Nath, Karthik
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S55 - S56
  • [8] Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Gagelmann, Nico
    Dima, Danai
    Merz, Maximilian
    Hashmi, Hamza
    Ahmed, Nausheen
    Tovar, Natalia
    Oliver-Caldes, Aina
    Stoelzel, Friedrich
    Rathje, Kristin
    Fischer, Luise
    Born, Patrick
    Schaefer, Lisa
    Albici, Anca-Maria
    Schub, Natalie
    Kfir-Erenfeld, Shlomit
    Assayag, Miri
    Asherie, Nathalie
    Wulf, Gerald Georg
    Kharboutli, Soraya
    Mueller, Fabian
    Shune, Leyla
    Davis, James A.
    Anwer, Faiz
    Vucinic, Vladan
    Platzbecker, Uwe
    Ayuk, Francis
    Kroeger, Nicolaus
    Khouri, Jack
    Gurnari, Carmelo
    McGuirk, Joseph
    Stepensky, Polina
    Abdallah, Al-Ola
    de Larrea, Carlos Fernandez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (14) : 1665 - 1675
  • [9] Treatment of relapsed or refractory multiple myeloma with bb2121 chimeric antigen receptor T cells
    Stocker, Nicolas
    HEMATOLOGIE, 2021, 27 (02): : 46 - 47
  • [10] BCMA-targeting chimeric antigen receptor T cell therapy for relapsed and/or refractory multiple myeloma
    Fang, Jiamin
    Zhou, Fuling
    ANNALS OF HEMATOLOGY, 2024, 103 (04) : 1069 - 1083
12345